SANDOZ LENALIDOMIDE
Identification of Sandoz Lenalidomide
No description |
Google image searchProduct monograph
Active ingredient
lenalidomide, 2.5 MG
DIN: 02518562
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: SANDOZ CANADA INCORPORATED
Date: 07-SEP-2021
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX04 — LENALIDOMIDE (ATC/DDD)
Reference brand drug: Revlimid
Pharmaceutical standard: MFR
External Links for Sandoz Lenalidomide
Search on Google
- Sandoz Lenalidomide side effects
- Sandoz Lenalidomide dosage
- lenalidomide side effects
- lenalidomide dosage
Sandoz Canada Incorporated
Go to Sandoz website to see drug product details. Sometimes you can find sandoz lenalidomide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.